Mar 02, 2011 00:30 EST P.U.L.S. AB A new molecule has been discovered by virus researchers at Umeå University. This important discovery was recently published in the well respected journal Nature Medicine. The molecule is essential to the virus that causes the serious eye disease epidemic keratoconjunctivitis (EKC). Currently, there is no approved therapy to treat this highly contagious eye infection.

Nov 18, 2010 04:36 EST SEKAB SEKAB E-Technology and Taurus Energy have successfully carried out a three-week long industrial demo scale evaluation of Taurus Energy's yeast. The yeast has been specially developed, and, in contrast to ordinary yeast, it can ferment pentose as well as hexose. It is a crucial step on the way towards commercialising a process for producing ethanol from cellulose-based raw materials.

Jun 21, 2010 12:00 EDT Viropharma DuoCort Pharma´s new physiological treatment for adrenal insufficiency improves patients’ quality of life. The company has also developed methods to optimize the dosage regimen which also contributes to an improvement in therapy over time. The Swedish pharmaceutical company presents this new data from its phase II/III trial at the 92nd annual ENDO congress in San Diego today.